Phytochemical Name : Clinacanthus nutans extract (CN)

Properties Information1 Information2
PhytoCAT-ID PhytoCAT-1612 PhytoCAT-1886
Phytochemical name or plant extracts Clinacanthus nutans extract (CN) Clinacanthus nutans extract (CN)
PMID 34379689
Literature evidence Overall, CN acts by ameliorating the pro-inflammatory condition in the TME and may be a potential strategy for its anticancer mechanism on highly metastatic breast cancer condition. However, only ethyl acetate extract caused the loss of mitochondrial membrane potential.
IUPAC name NA NA
Phytochemicals’ class or type of plant extracts Extract Methanolic extract, ethyl acetate extract
Source of phytochemicals or plant Extracts Clinacanthus nutans Clinacanthus nutansindau
Geographical availability Borneo, Cambodia, China South-Central, China Southeast, Hainan, Jawa, Laos, Lesser Sunda Is., Malaya, Thailand, Vietnam Borneo, Cambodia, China South-Central, China Southeast, Hainan, Jawa, Laos, Lesser Sunda Is., Malaya, Thailand, Vietnam
Plant parts Leaves Root
Other cancers Breast cancer Breast cancer, Cervical cancer
Target gene or protein IL-6, IL-1β, TNF-α. Bcl-2
Gene or Protein evidence CN extracts prevented the smoldering inflammation between cancer cells and immune cells by reducing the level of pro-inflammatory cytokines, such as IL-6, IL-1β and TNF-α. Although both root extracts exhibited apoptotic effect based on morphological changes and the suppression of BCL2 expression.
Target pathways LPS-induced production of pro-inflammatory cytokines were regulated by multiple pathways such as Nrf2/Keap1 and NF-κB pathways thus overlapping modulation of these pathways may have occurred at certain CN concentration as previously shown by other plant phytochemicals NA
IC50 NA Methanolic extract - 35 μg/mL against MCF-7 Ethyl acetate extract - 30 μg/mL against MCF-7
Potency CN was not cytotoxic to both MDA-MB-231 and THP-1 cells. The ability of MDA-MB-231 to migrate was also not halted by CN treatment. he results demonstrated that root extracts promote apoptosis by suppressing BCL2 via mitochondria-dependent or independent manner. The identified compounds might work solely or cooperatively in regulating apoptosis.
Cell line/ mice model MDA-MB-231 MCF-7, HTB-22, HeLa, CCL-2, NIH 3T3, CRL-1658
Additional information  TNF-α were significantly decreased after CN ethanol treatment at concentration 25- (p = 0.001), 50- (p = 0.000) and 100 μg/mL (p = 0.000). CN aqueous extract slightly inhibited TNF-α at all 25-50- and 100 μg/mL (p = 0.001, p = 0.000, p = 0.000, respectively). Overall, CN acts by ameliorating the pro-inflammatory condition in the TME and may be a potential strategy for its anticancer mechanism on highly metastatic breast cancer condition. The major pathways that link both cancer and inflammation were NF-κB and STATs thus further study on the upstream and downstream pathways is needed to fully understand the mechanism of CN extracts in cooling the inflamed TME in breast cancer. NA
PubChem ID NA
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:46937-1
Safety NA NA